Symbol classroom

PFS

Chart the move, read why OppHub America is covering it, then watch or talk it through — not a Google Finance clone.

PFS

TradingView chart · search any symbol inside the widget · informational only

Live chart & market data via TradingView · Delayed or exchange real-time per TradingView data agreements · Not investment advice

0 watching· join free Discuss in Community Join Community

Learn the move

Use this page as a short classroom: (1) scan the chart for the recent move, (2) read OppHub America Insider / Policy / company notes on PFS, (3) note what to watch next, then (4) add PFS to Watch or take the conversation to Community / Club.

Money angle — * Investors who purchased Regeneron Pharmaceuticals (NASDAQ: REGN) shares between August 1, 2025, and May 15, 2026, and experienced substantial losses are encouraged to review their legal options.

Latest coverage on PFS

Recent OppHub America stories tagged PFS — Insider, Policy, CEO Desk, and market catalysts

PFS policy →CEO Desk →Explore →

StoryAugust 4, 2026

$PFS

Regeneron Pharmaceuticals·$REGN

$ARM

Regeneron Faces Class Action Over Melanoma Trial Disclosures

Regeneron Pharmaceuticals (REGN) is facing a class action lawsuit filed by investors who purchased shares between August 1, 2025, and May 15, 2026. The suit alleges misleading statements regarding a Phase 3 melanoma trial, leading to a substantial market value drop.

* Investors who purchased Regeneron Pharmaceuticals (NASDAQ: REGN) shares between August 1, 2025, and May 15, 2026, and experienced substantial losses are encouraged to review their legal options.

Read desk note →Chart $PFS